MyD88-dependent pathway in T cells directly modulates the expansion of colitogenic CD4+ T cells in chronic colitis

Journal of Immunology

Volumn 180, Issue 8, 2008, Pages 5291-5299

  Tomita, Takayuki ^a   Kanai, Takanori ^a   Fujii, Toshimitsu ^a   Nemoto, Yasuhiro ^a   Okamoto, Ryuichi ^a   Tsuchiya, Kiichiro ^a   Totsuka, Teruji ^a   Sakamoto, Naoya ^a   Akira, Shizuo ^b   Watanabe, Mamoru ^a  

^a TOKYO MEDICAL AND DENTAL UNIVERSITY   (Japan)

^b OSAKA UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CARBOXYFLUORESCEIN DIACETATE SUCCINIMIDYL ESTER; GAMMA INTERFERON; INTERLEUKIN 17; MYELOID DIFFERENTIATION FACTOR 88; PROTEIN BCL 2; PROTEIN BCL XL; RAG2 PROTEIN; TOLL LIKE RECEPTOR; MYD88 PROTEIN, MOUSE;

ADOPTIVE TRANSFER; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CELL SURVIVAL; COLITIS; COMPARATIVE STUDY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; KINETICS; LAMINA PROPRIA; LYMPHOCYTE PROLIFERATION; MEMORY CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; T LYMPHOCYTE; ANIMAL; CHRONIC DISEASE; IMMUNOLOGY; METABOLISM; MOUSE MUTANT;

ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; CHRONIC DISEASE; COLITIS; MICE; MICE, MUTANT STRAINS; MYELOID DIFFERENTIATION FACTOR 88; SIGNAL TRANSDUCTION; TOLL-LIKE RECEPTORS;

EID: 45949091032     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.180.8.5291     Document Type: Article

References (31)

1. Podolsky, D. K. 2002. Inflammatory bowel disease. N. Engl. J. Med. 347: 417-429.
2. Baumgart, D. C, and S. R. Carding. 2007. Inflammatory bowel disease: cause and immunobiology. Lancet 369: 1627-1640.
3. Strober, W., I. J. Fuss, and R. S. Blumberg. 2002. The immunology of mucosal models of inflammation. Annu. Rev. Immunol. 20: 495-549.
4. Seksik, P., H. Sokol, P. Lepage, N. Vasquez, C. Manichanh, I. Mangin, P. Pochart, J. Dore, and P. Marteau. 2006. Review article: the role of bacteria in onset and perpetuation of inflammatory bowel disease. Aliment. Pharmacol. Ther. 24 (Suppl. 3) : 11-18.
5. Sartor, R. B. 2006. Mechanisms of disease: pathogenesis of Crohn's disease and ulcerative colitis. Nat. Clin. Pract. Gastroenterol. Hepatol. 3: 390-407.
6. Izcue, A., J. L. Coombes, and F. Powrie. 2006. Regulatory T cells suppress systemic and mucosal immune activation to control intestinal inflammation. Immunol. Rev. 212: 256-271.
7. Bamias, G., M. R. Nyce, S. A. De La Rue, and F. Cominelli. 2005. New concepts in the patho physio logy of inflammatory bowel disease. Ann. Intern. Med. 143: 895-904.
8. Hibi, T., and H. Ogata. 2006. Novel pathophysiological concepts of inflammatory bowel disease. J. Gastroenterol. 41: 10-16.
9. Akira, S., S. Uematsu, and O. Takeuchi. 2006. Pathogen recognition and innate immunity. Cell 124: 783-801.
10. Rakoff-Nahoum, S., and R. Medzhitov. 2006. Role of the innate immune system and host-commensal mutualism. Curr. Top. Microbiol. Immunol. 308: 1-18.
11. Schnare, M., G. M. Barton, A. C. Holt, K. Takeda, S. Akira, and R. Medzhitov. 2001. Toll-like receptors control activation of adaptive immune responses. Nat. Immunol. 2: 947-950.
12. Kabelitz, D. 2007. Expression and function of Toll-like receptors in T lymphocytes. Curr. Opin. Immunol. 19: 39-45.
13. Adachi, O., T. Kawai, K. Takeda, M. Matsumoto, H. Tsutsui, M. Sakagami, K. Nakanishi, and S. Akira. 1998. Targeted disruption of the My D88 gene results in loss of IL-1- and IL-18-mediated function. Immunity 9: 143-150.
14. Medzhitov, R., P. Preston-Hurlburt, E. Kopp, A. Stadlen, C. Chen, S. Ghosh, and C. A. Janeway, Jr. 1998. MyD88 is an adaptor protein in the hToll/IL-1 receptor family signaling pathways. Moll. Cell 2: 50-53.
15. Totsuka, T., T. Kanai, R. Iiyama, K. Uraushihara, M. Yamazaki, R. Okamoto, T. Hibi, K. Tezuka, M. Azuma, H. Akiba, et al. 2003. Ameliorating effect of anti-ICOS monoclonal antibody in a murine model of chronic colitis. Gastroenterology 124: 410-421.
16. Caramalho, I., T. Lopes-Carvalho, D. Ostler, S. Zelenay, M. Haury, and J. Demengeot. 2003. Regulatory T cells selectively express toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med. 197: 403-411.
17. - effector memory T cells. Am. J. Physiol. 290: G1051-G1058.
18. Totsuka, T., T Kanai, Y. Nemoto, S. Makita, R. Okamoto, K. Tsuchiya, and M. Watanabe. 2007. IL-7 is essential for the development and the persistence of chronic colitis. J. Immunol. 178: 4737-4748.
19. Surh, C. D., O. Boyman, J. F. Purton, and J. Sprent. 2006. Homeostasis of memory T cells. Immunol. Rev. 211: 154-163.
20. + regulatory T cells is a suppressive site of intestinal inflammation. J. Immunol. 178: 4937-4946.
21. Kaisho, T., and S. Akira. 2001. Dendritic-cell function in Toll-like receptor- and MyD88-knockout mice. Trends Immunol. 22: 78-83.
22. Bradley, L. M., L. Haynes, and S. L. Swain. 2005. IL-7: maintaining T-cell memory and achieving homeostasis. Trends Immunol. 26: 172-176.
23. Seddon, B., P. Tomlinson, and R. Zamoyska. 2003. Interleukin 7 and T cell receptor signals regulate homeostasis of CD4 memory cells. Nat. Immunol. 4: 680-686.
24. Picker, L. J., E. F. Reed-Inderbitzin, S. I. Hagen, J. B. Edgar, S. G. Hansen, A. Legasse, S. Planer, M. Piatak, Jr., J. D. Lifson, V. C. Maino, et al. 2006. IL-15 induces CD4 effector memory T cell production and tissue emigration in nonhuman primates. J. Clin. Invest. 116: 1514-1524.
25. Iqbal, N., J. R. Oliver, F. H. Wagner, A. S. Lazenby, C. O. Elson, and C. T. Weaver. 2002. T helper 1 and T helper 2 cells are pathogenic in an antigenspecific model of colitis. J. Exp. Med. 195: 71-84.
26. Yoshida, M., T. Watanabe, T Usui, Y. Matsunaga, Y. Shirai, M. Yamori, T. Itoh, S. Habu, T Chiba, T. Kita, and Y. Wakatsuki. 2001. T cells monospecific to ovalbumin produced by Escherichia coli can induce colitis upon transfer to BALB/c and SCID mice. Int. Immunol. 13: 1561-1570.
27. + T cells and enables CpG oligodeoxynucleotide- mediated costimulation. Immunity 25: 783-793.
28. Klenerman, P., and A. Hill. 2005. T cells and viral persistence: lessons from diverse infections. Nat. Immunol. 6: 873-879.
29. + memory T cells are long lived. Immunol. Rev. 211: 49-57.
30. Zaph, C, J. Uzonna, S. M. Beverley, and P. Scott. 2004. Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat. Med. 10: 1104-1110.
31. Stallmach, A., and O. Carstens. 2002. Role of infections in the manifestation or reactivation of inflammatory bowel diseases. Inflamm. Bowel. Dis. 8: 213-218.